All Stories

  1. Environmental risk of nontuberculous mycobacterial infection: Strategies for advancing methodology
  2. Quantifying the effectiveness of ultraviolet-C light at inactivating airborne Mycobacterium abscessus
  3. ‘Teach me how to look after myself’: What people with bronchiectasis want from education in a pulmonary rehabilitation setting
  4. Characterizing and correcting immune dysfunction in non-tuberculous mycobacterial disease
  5. Carriage and Transmission of Macrolide Resistance Genes in Patients With Chronic Respiratory Conditions and Their Close Contacts
  6. CD161 expression defines new human γδ T cell subsets
  7. Factors associated with “Frequent Exacerbator” phenotype in children with bronchiectasis: The first report on children from the Australian Bronchiectasis Registry
  8. Investigation of C-reactive protein and AIM2 methylation as a marker for PTSD in Australian Vietnam veterans
  9. Dissemination of Mycobacterium abscessus via global transmission networks
  10. Use of inhaled GM-CSF in treatment-refractory NTM infection. An open-label, exploratory clinical trial
  11. Amikacin Liposome Inhalation Suspension for Refractory Mycobacterium avium Complex Lung Disease
  12. Amikacin Liposome Inhalation Suspension for Mycobacterium avium Complex Lung Disease: A 12-Month Open-Label Extension Clinical Trial
  13. Clinical Pharmacokinetic and Pharmacodynamic Considerations in the Drug Treatment of Non-Tuberculous Mycobacteria in Cystic Fibrosis
  14. Influence of climate variables on the rising incidence of nontuberculous mycobacterial (NTM) infections in Queensland, Australia 2001–2016
  15. Management of Drug Toxicity in Mycobacterium avium Complex Pulmonary Disease: An Expert Panel Survey
  16. Factor structure of posttraumatic stress disorder (PTSD) in Australian Vietnam Veterans: Confirmatory factor analysis of the Clinician-Administered PTSD Scale for DSM–5
  17. The Epidemiology of Extrapulmonary Non-tuberculous Mycobacterial Infection in a Pediatric Population
  18. The Rise of Non-Tuberculosis Mycobacterial Lung Disease
  19. Management of Australian Adults with Bronchiectasis in Tertiary Care: Evidence-Based or Access-Driven?
  20. Nontuberculosis mycobacteria infections: would there be pharmacodynamics without pharmacokinetics?
  21. The clinical significance of Mycobacterium triplex
  22. DNA methylation from germline cells in veterans with PTSD
  23. Inhaled therapies for NTM disease – The way forward?
  24. Australian adults with bronchiectasis: The first report from the Australian Bronchiectasis Registry
  25. Comparison of Sleep Patterns in Vietnam Veterans With and Without Posttraumatic Stress Disorder Using Wrist Actigraphy
  26. Resilience and psychopathology in trauma-exposed Australian Veterans: An exploratory factor analysis of the Connor-Davidson Resilience Scale
  27. Transmission of bacteria in bronchiectasis and chronic obstructive pulmonary disease: Low burden of cough aerosols
  28. Mycobacterium abscessus pulmonary disease: individual patient data meta-analysis
  29. Exploring immunomodulation by endocrine changes in Lady Windermere syndrome
  30. Multi-Centre Ethics and Research Governance Review Can Impede Non-Interventional Clinical Research
  31. Amikacin Liposome Inhalation Suspension for Treatment-Refractory Lung Disease Caused by Mycobacterium avium Complex (CONVERT): A Prospective, Open-Label, Randomized Study
  32. Anomalies in T Cell Function Are Associated With Individuals at Risk of Mycobacterium abscessus Complex Infection
  33. Sleep Disturbances in Australian Vietnam Veterans With and Without Posttraumatic Stress Disorder
  34. Impact of Long-Term Erythromycin Therapy on the Oropharyngeal Microbiome and Resistance Gene Reservoir in Non-Cystic Fibrosis Bronchiectasis
  35. Treatment outcome definitions for nontuberculous mycobacterial pulmonary disease
  36. Mycobacterium shimoidei, a Rare Pulmonary Pathogen, Queensland, Australia
  37. Physical comorbidities of post-traumatic stress disorder in Australian Vietnam War veterans
  38. Susceptibility to non-tuberculous mycobacterial disease is influenced by rs1518111 in IL10
  39. Notification of Nontuberculous Mycobacteria: An Australian Perspective
  40. A haplotype spanning P2X7R, P2X4R and CAMKK2 may mark susceptibility to pulmonary non-tuberculous mycobacterial disease
  41. Emergence and spread of a human-transmissible multidrug-resistant nontuberculous mycobacterium
  42. Culture-Independent Detection of Nontuberculous Mycobacteria in Clinical Respiratory Samples
  43. Is Pulmonary non-Tuberculous Mycobacterial Disease Linked with a High Burden of Latent Cytomegalovirus?
  44. Safety of IV amikacin in the treatment of pulmonary non‐tuberculous mycobacterial disease
  45. Nontuberculous Mycobacterial Lung Disease. Time to Get a Grip!
  46. Review: Environmental mycobacteria as a cause of human infection
  47. Rapidly Growing Mycobacteria Associated with Laparoscopic Gastric Banding, Australia, 2005–2011
  48. A spatial epidemiological analysis of nontuberculous mycobacterial infections in Queensland, Australia
  49. Strain variation amongst clinical and potable water isolates of M. kansasii using automated repetitive unit PCR
  50. Levels of anti-cytokine antibodies may be elevated in patients with pulmonary disease associated with non-tuberculous mycobacteria
  51. Heterogeneity of clinical and environmental isolates ofMycobacterium fortuitumusing repetitive element sequence-based PCR: municipal water an unlikely source of community-acquired infections
  52. Searching for an immunogenetic factor that will illuminate susceptibility to non-tuberculous mycobacterial disease
  53. Isolation of Nontuberculous Mycobacteria (NTM) from Household Water and Shower Aerosols in Patients with Pulmonary Disease Caused by NTM
  54. Mycobacterium abscessus isolated from municipal water - a potential source of human infection
  55. The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: an NTM-NET collaborative study
  56. Factors associated with the isolation of Nontuberculous mycobacteria (NTM) from a large municipal water system in Brisbane, Australia
  57. Mycobacterium Abscessus Infection And Potable Water
  58. Pathogenic Nontuberculous Mycobacteria In The Brisbane Potable Water Distribution System
  59. Mycobacterium lentiflavum in Drinking Water Supplies, Australia
  60. Changing Epidemiology of Pulmonary Nontuberculous Mycobacteria Infections
  61. Clinical Significance ofMycobacterium asiaticumIsolates in Queensland, Australia
  62. When and how to treat pulmonary non-tuberculous mycobacterial diseases
  63. Comparison of Methods for Processing Drinking Water Samples for the Isolation of Mycobacterium avium and Mycobacterium intracellulare
  64. Gastroesophageal Reflux Disease, Acid Suppression, and Mycobacterium avium Complex Pulmonary Disease
  65. Sesame seed products contaminated with Salmonella : three outbreaks associated with tahini
  66. Cytomegalovirus retinitis, human immunodeficiency virus antibody positivity and normal T helper cell numbers
  67. Diagnosis, classification and epidemiology of pulmonary nontuberculous mycobacterial disease